PATENT CLAIM ANALYSIS

Application Number: 15894025
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "215000"]

Abstract:
The present invention relates to novel compounds and methods for the manufacture of inhibitors of deubiquitylating enzymes (DUBs). In particular, the invention relates to the inhibition of ubiquitin C-terminal hydrolase L1 (UCHL1). The invention further relates to the use of DUB inhibitors in the treatment of cancer and other indications. Compounds of the invention include compounds having the formula (I) or a pharmaceutically acceptable salt thereof, wherein R1 to R8 are as defined herein.

Claim (Index 25):
The compound according to  claim 18 , wherein R 2 , R 3 , R 4 , R 5 , R 6 , R 7  and R 8  each independently represent hydrogen.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 88.0
- Lexical Diversity: 1.56364
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15513125', '16070936', '16060299', '15738900', '16080506']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.832270051450775
- 35 USC 102 Novelty (BERT): 0.6452969970395721
- Combined Prediction Score: 0.8135727460096547
- Mean Citation Score: 564.0303700000002
- Max Citation Score: 695.69135
- Similarity Product: 547.2017435596557

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test